Skip to Content

Z300 (Caprelsa 300 mg)

Generic Name: vandetanib

This pill with imprint "Z300" is White, Elliptical / Oval and has been identified as Caprelsa 300 mg. It is supplied by Genzyme Corporation.

Caprelsa is used in the treatment of thyroid cancer and belongs to the drug classes EGFR inhibitors, multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Caprelsa 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for Z300

Caprelsa

Generic Name:
vandetanib
Imprint:
Z300
Strength:
300 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
EGFR inhibitors
Multikinase inhibitors
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Genzyme Corporation
National Drug Code (NDC):
00310-7840

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide